Newsroom

Newsroom

NeoGenomics Appoints Lynn Tetrault Interim CEO

Press Release
Read More

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR® MRD and InVisionFirst®-Lung Tests at the 2022 ASCO Annual Meeting

Press Release
Read More

NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary

Press Release
Read More

Diagnostic Symposium

Blog
Read More

NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference

Press Release
Read More

Travelogue 1

Blog
Read More

NeoGenomics Reports Revenue of $117 Million in the First Quarter

Press Release
Read More

NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients